Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can increase the risk ...
Stopping Alzheimer’s Before It Starts: Landmark Trial Enrolls First Participants
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...
PMLiVE6d
Eli Lilly and OliX partner to advance early-stage metabolic disease candidate
Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a ...
News Medical7d
Inhaled antibody therapy shows promise for COVID-19 treatment
A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high antibody levels in the airway—offering a faster and more effective way to fight COVID-19.
Yahoo Finance14d
Lilly’s investigational Alzheimer’s to be investigated in prevention trial
A US university has launched a prevention trial examining the use of Eli Lilly’s investigational ... determine if the investigational monoclonal antibody remternetug can remove plaques of ...
labiotech7d
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
Monoclonal Antibodies: A New Era In Alzheimer's Treatment
Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer's disease, offering hope for slowing its progression. T ...